Track the 润达医疗 share price and the full insider trade history of the company, a publicly traded company based in China. Shares are listed on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 润达医疗 has published 10 insider filings. Market capitalisation: €9bn. The latest transaction was filed on 14 January 2026 (Sale). Among the most active insiders: 陈政. All data is free.
10
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
10 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 20,218 of 25,973 companies
32.2
score / 100
Value
44
Quality
20
FCF yld6.8%
Earn yld-9.6%
EV/EBITDA·
ROE-9.7%
Gross mgn21%
Net mgn-7.8%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.